A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant Gag epitopes during chronic human immunodeficiency virus infection

被引:11
作者
Geldmacher, Christof [1 ,2 ]
Gray, Clive [5 ]
Nason, Martha [1 ]
Currier, Jeffrey R. [4 ]
Haule, Antelmo [2 ]
Njovu, Lilian [2 ]
Geis, Steffen [2 ]
Hoffmann, Oliver [2 ]
Maboko, Leonard [2 ]
Meyerhans, Andreas [6 ]
Cox, Josephine [4 ]
Hoelscher, Michael [3 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Referral Hosp, Mbeya Med Res Programme, Mbeya, Tanzania
[3] Univ Munich, Dept Trop Med & Infect Dis, D-80799 Munich, Germany
[4] US Mil HIV Res Program, Rockville, MD 20851 USA
[5] Natl Inst Communicable Dis, Johannesburg, South Africa
[6] Univ Saarland, Inst Virol, D-66421 Homburg, Germany
关键词
D O I
10.1128/JVI.01566-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus (HIV)-specific CD8 T-cell responses targeting products encoded within the Gag open reading frame have frequently been associated with better viral control and disease outcome during the chronic phase of HIV infection. To further clarify this relationship, we have studied the dynamics of Gag-specific CD8 T-cell responses in relation to plasma viral load and time since infection in 33 chronically infected subjects over a 9-month period. High baseline viral loads were associated with a net loss of breadth (P < 0.001) and a decrease in the total magnitude of the Gag-specific T-cell response in general (P = 0.03). Most importantly, the baseline viral load predicted the subsequent change in the breadth of Gag recognition over time (P < 0.0001, r(2) = 0.41). Compared to maintained responses, lost responses were low in magnitude (P < 0.0001) and subdominant in the hierarchy of Gag-specific responses. The present study indicates that chronic exposure of the human immune system to high levels of HIV viremia is a determinant of virus-specific CD8 T-cell loss.
引用
收藏
页码:13809 / 13815
页数:7
相关论文
共 36 条
[1]   Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load [J].
Addo, MM ;
Yu, XG ;
Rathod, A ;
Cohen, D ;
Eldridge, RL ;
Strick, D ;
Johnston, MN ;
Corcoran, C ;
Wurcel, AG ;
Fitzpatrick, CA ;
Feeney, ME ;
Rodriguez, WR ;
Basgoz, N ;
Draenert, R ;
Stone, DR ;
Brander, C ;
Goulder, PJR ;
Rosenberg, ES ;
Altfeld, M ;
Walker, BD .
JOURNAL OF VIROLOGY, 2003, 77 (03) :2081-2092
[2]   Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection [J].
Altfeld, M ;
Addo, MA ;
Rosenberg, ES ;
Hecht, FA ;
Lee, PK ;
Vogel, M ;
Yu, XG ;
Draenert, R ;
Johnston, MN ;
Strick, D ;
Allen, TA ;
Feeney, ME ;
Kahn, JO ;
Sekaly, RP ;
Levy, JA ;
Rockstroh, JK ;
Goulder, PJR ;
Walker, BD .
AIDS, 2003, 17 (18) :2581-2591
[3]   Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection [J].
Altfeld, M ;
Rosenberg, ES ;
Shankarappa, R ;
Mukherjee, JS ;
Hecht, FM ;
Eldridge, RL ;
Addo, MM ;
Poon, SH ;
Phillips, MN ;
Robbins, GK ;
Sax, PE ;
Boswell, S ;
Kahn, JO ;
Brander, C ;
Goulder, PJR ;
Levy, JA ;
Mullins, JI ;
Walker, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :169-180
[4]   Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations [J].
Bailey, Justin R. ;
Williams, Thomas M. ;
Siliciano, Robert F. ;
Blankson, Joel N. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (05) :1357-1369
[5]   Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes [J].
Bernardin, F ;
Kong, D ;
Peddada, L ;
Baxter-Lowe, LA ;
Delwart, E .
JOURNAL OF VIROLOGY, 2005, 79 (17) :11523-11528
[6]   Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection [J].
Betts, MR ;
Ambrozak, DR ;
Douek, DC ;
Bonhoeffer, S ;
Brenchley, JM ;
Casazza, JP ;
Koup, RA ;
Picker, LJ .
JOURNAL OF VIROLOGY, 2001, 75 (24) :11983-11991
[7]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[8]   A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays [J].
Currier, JR ;
Kuta, EG ;
Turk, E ;
Earhart, LB ;
Loomis-Price, L ;
Janetzki, S ;
Ferrari, G ;
Birx, DL ;
Cox, JH .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 260 (1-2) :157-172
[9]   Weak anti-HIV CD8+ T-cell effector activity in HIV primary infection [J].
Dalod, M ;
Dupuis, M ;
Deschemin, JG ;
Goujard, C ;
Deveau, C ;
Meyer, L ;
Ngo, N ;
Rouzioux, C ;
Guillet, JG ;
Delfraissy, JF ;
Sinet, M ;
Venet, A .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (10) :1431-1439
[10]   PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression [J].
Day, Cheryl L. ;
Kaufmann, Daniel E. ;
Kiepiela, Photini ;
Brown, Julia A. ;
Moodley, Eshia S. ;
Reddy, Sharon ;
Mackey, Elizabeth W. ;
Miller, Joseph D. ;
Leslie, Alasdair J. ;
DePierres, Chantal ;
Mncube, Zenele ;
Duraiswamy, Jaikumar ;
Zhu, Baogong ;
Eichbaum, Quentin ;
Altfeld, Marcus ;
Wherry, E. John ;
Coovadia, Hoosen M. ;
Goulder, Philip J. R. ;
Klenerman, Paul ;
Ahmed, Rafi ;
Freeman, Gordon J. ;
Walker, Bruce D. .
NATURE, 2006, 443 (7109) :350-354